tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

IOVA Stock Latest News

Iovance Biotherapeutics’ Lifileucel-Pembrolizumab Study: A Potential Game-Changer in Melanoma Treatment
Company AnnouncementsIovance Biotherapeutics’ Lifileucel-Pembrolizumab Study: A Potential Game-Changer in Melanoma Treatment
1d ago
IOVA
Iovance Biotherapeutics CFO Resignation and Interim Appointment
PremiumCompany Announcements
Iovance Biotherapeutics CFO Resignation and Interim Appointment
6d ago
8K
IOVA
Iovance Biotherapeutics Advances in Melanoma Treatment with Lifileucel-Pembrolizumab Study
PremiumCompany Announcements
Iovance Biotherapeutics Advances in Melanoma Treatment with Lifileucel-Pembrolizumab Study
6d ago
IOVA
Iovance Biotherapeutics Advances LN-145 Therapy in NSCLC Study
PremiumCompany Announcements
Iovance Biotherapeutics Advances LN-145 Therapy in NSCLC Study
13d ago
IOVA
IOVA Lawsuit Alert! Class Action Lawsuit Against Iovance Biotherapeutics
PremiumMarket News
IOVA Lawsuit Alert! Class Action Lawsuit Against Iovance Biotherapeutics
19d ago
IOVA
Iovance Biotherapeutics CFO Resignation Announced
PremiumCompany AnnouncementsIovance Biotherapeutics CFO Resignation Announced
26d ago
8K
IOVA
Iovance Biotherapeutics Approves Key Proposals at Annual Meeting
Premium
Company Announcements
Iovance Biotherapeutics Approves Key Proposals at Annual Meeting
29d ago
8K
IOVA
Unusually active option classes on open June 9th
Premium
The Fly
Unusually active option classes on open June 9th
1M ago
KSS
UNG
Iovance Biotherapeutics announces publication of five-year analysis of Amtagvi
PremiumThe Fly
Iovance Biotherapeutics announces publication of five-year analysis of Amtagvi
1M ago
IOVA
Promising Developments and Strategic Advantages Drive Buy Rating for Iovance Biotherapeutics
PremiumRatings
Promising Developments and Strategic Advantages Drive Buy Rating for Iovance Biotherapeutics
1M ago
IOVA
Promising Potential of Iovance Biotherapeutics’ AMTAGVI: Analyst Recommends Buy Rating Based on Impressive Efficacy and Market Opportunities
PremiumRatings
Promising Potential of Iovance Biotherapeutics’ AMTAGVI: Analyst Recommends Buy Rating Based on Impressive Efficacy and Market Opportunities
1M ago
IOVA
Iovance Biotherapeutics announces five-year results of Amtagvi in melanoma
PremiumThe Fly
Iovance Biotherapeutics announces five-year results of Amtagvi in melanoma
2M ago
IOVA
Qualcomm, Algonquin, Target, Iovance, ON: Trending by Analysts
PremiumWeekend UpdatesQualcomm, Algonquin, Target, Iovance, ON: Trending by Analysts
2M ago
ON
AQN
Cautious Outlook for Iovance Biotherapeutics Amid Amtagvi Sales Challenges
Premium
Ratings
Cautious Outlook for Iovance Biotherapeutics Amid Amtagvi Sales Challenges
2M ago
IOVA
Iovance Biotherapeutics downgraded to Neutral from Buy at UBS
Premium
The Fly
Iovance Biotherapeutics downgraded to Neutral from Buy at UBS
2M ago
IOVA
Investors Take Action Against Iovance’s Misleading Growth Claims
PremiumClass Action
Investors Take Action Against Iovance’s Misleading Growth Claims
2M ago
IOVA
Target downgraded, Wayfair upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Target downgraded, Wayfair upgraded: Wall Street’s top analyst calls
2M ago
W
ON
Iovance Biotherapeutics price target lowered to $10 from $30 at Mizuho
PremiumThe Fly
Iovance Biotherapeutics price target lowered to $10 from $30 at Mizuho
2M ago
IOVA
Iovance Biotherapeutics downgraded to Hold from Buy at Truist
PremiumThe Fly
Iovance Biotherapeutics downgraded to Hold from Buy at Truist
2M ago
IOVA
Iovance Biotherapeutics price target lowered to $4 from $5 at Barclays
PremiumThe FlyIovance Biotherapeutics price target lowered to $4 from $5 at Barclays
2M ago
IOVA
Iovance Biotherapeutics’ Earnings Call: Mixed Sentiments and Future Prospects
Premium
Company Announcements
Iovance Biotherapeutics’ Earnings Call: Mixed Sentiments and Future Prospects
2M ago
IOVA
Qualcomm initiated, Lyft upgraded: Wall Street’s top analyst calls
Premium
The Fly
Qualcomm initiated, Lyft upgraded: Wall Street’s top analyst calls
2M ago
ROK
AFRM

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >